Print this page Email this page
Users Online: 336
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
Year : 2018  |  Volume : 32  |  Issue : 1  |  Page : 22-26

A comparative study on antifungal susceptibility of Penicillium marneffei (Talaromyces marneffei) and nonmarneffei Penicillium species

Department of Microbiology, Regional Institute of Medical Sciences, Lamphelpat, Imphal, Manipur, India

Correspondence Address:
Dr. Khuraijam Ranjana Devi
Department of Microbiology, Regional Institute of Medical Sciences, Lamphelpat, Imphal - 795 004, Manipur
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jms.jms_38_17

Rights and Permissions

Background: The fungus Penicillium can cause various infectious diseases in humans and animals. Being present in the environment, its importance in human health has been neglected and is often interpreted as room contaminant. Treatment of regional penicilliosis caused by dimorphic Penicillium marneffei has been according to the protocol available in literature. Objective: The study was conducted to determine the antifungal susceptibility pattern of endemic P. marneffei and other nonmarneffei (NM) Penicillium species in Manipur. Materials and Methods: Clinical and environmental Penicillium species were isolated using standard operating procedure. Antifungal susceptibility of five antifungal agents, namely amphotericin B, voriconazole, itraconazole, fluconazole, and natamycin, was carried out according to the Clinical and Laboratory Standards Institute (CLSI, M38–A2) guidelines. Results: All P. marneffei isolates (100%) showed sensitivity to amphotericin B at ≤1 μg/ml, whereas 96.5% and 76.3% of clinical and environmental NM Penicillium isolates, respectively, were sensitive at ≤1 μg/ml. Clinical isolates were completely inhibited at a concentration of ≤0.25 μg/ml of voriconazole. 30.7% P. marneffei were susceptible at lower minimum inhibitory concentration (MIC) of 0.06 μg/ml of itraconazole, but 31.4% of environmental isolates noted a high MICs of ≥0.5 μg/ml. There was no significant difference in fluconazole MIC among tested strains; however, 10.5% of environmental strains noted higher MIC at 150 μg/ml. 16 μg/ml of natamycin inhibited 100%, 86.2%, and 84.2% of P. marneffei and clinical and environmental NM Penicillium species, respectively. Conclusion: Itraconazole and voriconazole are the drugs of choice for the management of infection caused by P. marneffei and NM Penicillium species. Environmental NM Penicillium isolates with higher MICs may be because of exposure to agricultural fungicides.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded278    
    Comments [Add]    

Recommend this journal